Community perceptions of a malaria vaccine in the Kintampo districts of Ghana
Community perceptions of a malaria vaccine in the Kintampo districts of Ghana
复制标题
DOI：
10.1186/1475-2875-12-156
复制
发表时间：
2013-05-07
期刊：
影响因子：
3
通讯作者：
Owusu-Agyei, Seth
中科院分区：
文献类型：
--
作者：
Febir, Lawrence G.;Asante, Kwaku P.;Owusu-Agyei, Seth
背景：尽管目前有控制疟疾的手段，但疟疾仍然是撒哈拉以南非洲发病率和死亡率的主要原因。提供疟疾疫苗供日常使用将是一个主要标志，但社区成员和保健系统内的保健专业人员接受疟疾疫苗可能构成相当大的挑战，西非部分地区采用小儿麻痹症疫苗就是一个例子。其中一些挑战可能是预料不到的，因为人们所做的决定往往是由无数复杂的感知驱动的。本文报道的知识和观念的社区成员在加纳的Kintampo地区疟疾疫苗试验一直在进行的驱动器的一部分，有史以来第一个许可的疟疾疫苗在不久的将来。方法：定性和定量的方法都被用于数据收集过程中。邀请其子女参与或未参与疟疾疫苗试验的妇女和男子参加焦点小组讨论（FGD）。由研究地区宗教团体负责人、卫生保健提供者、传统医士和传统助产士组成的受访者也应邀参加了深入访谈。在进行疟疾疫苗试验（Mal 047RTS，S）的社区进行横断面调查。共进行了12个FGD，15个IDIs和466个户主访谈。受访者希望他们的孩子接种疫苗，以预防包括疟疾在内的所有儿童疾病。与最近于2002年引入的B型肝炎和B型流感嗜血杆菌疫苗相比，受访者对长期存在的常规疫苗的了解相对较高。有没有明确的宗教信仰或社会文化习俗，将作为一个可能的障碍，接受疟疾vaccine.Conclusion：假设疟疾疫苗将是有效的其他EPI疫苗，在加纳中部的社区成员将接受和更喜欢疟疾疫苗疟疾药物作为疟疾控制工具。在接受调查的社区中，信仰和文化习俗是接受疟疾疫苗的障碍，这一点几乎不为人所知。
Background: Malaria remains the leading cause of morbidity and mortality in sub-Saharan Africa despite tools currently available for its control. Making malaria vaccine available for routine use will be a major hallmark, but its acceptance by community members and health professionals within the health system could pose considerable challenge as has been found with the introduction of polio vaccinations in parts of West Africa. Some of these challenges may not be expected since decisions people make are many a time driven by a complex myriad of perceptions. This paper reports knowledge and perceptions of community members in the Kintampo area of Ghana where malaria vaccine trials have been ongoing as part of the drive for the first-ever licensed malaria vaccine in the near future.Methods: Both qualitative and quantitative methods were used in the data collection processes. Women and men whose children were or were not involved in the malaria vaccine trial were invited to participate in focus group discussions (FGDs). Respondents, made up of heads of religious groupings in the study area, health care providers, traditional healers and traditional birth attendants, were also invited to participate in in-depth interviews (IDIs). A cross-sectional survey was conducted in communities where the malaria vaccine trial (Mal 047RTS,S) was carried out. In total, 12 FGDs, 15 IDIs and 466 household head interviews were conducted.Results: Knowledge about vaccines was widespread among participants. Respondents would like their children to be vaccinated against all childhood illnesses including malaria. Knowledge of the long existing routine vaccines was relatively high among respondents compared to hepatitis B and Haemophilus influenza type B vaccines that were introduced more recently in 2002. There was no clear religious belief or sociocultural practice that will serve as a possible barrier to the acceptance of a malaria vaccine.Conclusion: With the assumption that a malaria vaccine will be as efficacious as other EPI vaccines, community members in Central Ghana will accept and prefer malaria vaccine to malaria drugs as a malaria control tool. Beliefs and cultural practices as barriers to the acceptance of malaria vaccine were virtually unknown in the communities surveyed.